Results of a survey on the treatment of adolescents and young adult (AYA) sarcoma patients in Spain at present time
Introduction We aimed to analyse health care services for adolescents and young adults (AYA) with sarcomas in Spain. Methods A survey was sent to all Spanish cancer centres, including questions about demographic, facilities, and treatment strategies for AYAs with sarcomas in the last 2 years. Result...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Mata Fernández, Cristina [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2022 |
|---|
| Schlagwörter: |
|---|
| Anmerkung: |
© The Author(s), under exclusive licence to Federación de Sociedades Españolas de Oncología (FESEO) 2022. Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. |
|---|
| Übergeordnetes Werk: |
Enthalten in: Revista de oncología - Barcelona : Doyma, 2000, 24(2022), 12 vom: 21. Aug., Seite 2475-2479 |
|---|---|
| Übergeordnetes Werk: |
volume:24 ; year:2022 ; number:12 ; day:21 ; month:08 ; pages:2475-2479 |
| Links: |
|---|
| DOI / URN: |
10.1007/s12094-022-02912-w |
|---|
| Katalog-ID: |
SPR048361720 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR048361720 | ||
| 003 | DE-627 | ||
| 005 | 20230509113857.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 221015s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s12094-022-02912-w |2 doi | |
| 035 | |a (DE-627)SPR048361720 | ||
| 035 | |a (SPR)s12094-022-02912-w-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Mata Fernández, Cristina |e verfasserin |0 (orcid)0000-0001-9922-0078 |4 aut | |
| 245 | 1 | 0 | |a Results of a survey on the treatment of adolescents and young adult (AYA) sarcoma patients in Spain at present time |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © The Author(s), under exclusive licence to Federación de Sociedades Españolas de Oncología (FESEO) 2022. Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. | ||
| 520 | |a Introduction We aimed to analyse health care services for adolescents and young adults (AYA) with sarcomas in Spain. Methods A survey was sent to all Spanish cancer centres, including questions about demographic, facilities, and treatment strategies for AYAs with sarcomas in the last 2 years. Results Thirty-five units participated in the survey, 17 paediatric and 15 adult units. There were three specialized AYA units. First line regimen varied depending on whether the treating unit was paediatric or not, for osteosarcomas, rhabdomyosarcomas, and non-rhabdomyosarcomas. By contrast, 91.4% of Ewing sarcomas were treated according to EE2012. In the relapse setting, differences between units were higher in all tumours. Additionally, 48% of the units reported not having trials for this population. Conclusion There are major differences in the treatment of AYAs with sarcomas between adult and paediatric units. Enormous efforts are needed to homogenize treatments and increase the access to innovation. | ||
| 650 | 4 | |a Adolescents |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a AYA oncology |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Sarcoma |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Clinical trials |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a AYA units |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a GEIS-SEHOP |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Gutierrez Carrasco, Nacho |4 aut | |
| 700 | 1 | |a Juan Ribelles, Antonio |4 aut | |
| 700 | 1 | |a Hindi Muñiz, Nadia |4 aut | |
| 700 | 1 | |a Estival González, Anna |4 aut | |
| 700 | 1 | |a Rubio San Simón, Alba |4 aut | |
| 700 | 1 | |a Portellano, Lucía Castillo |4 aut | |
| 700 | 1 | |a Medina, Sofía Ruiz |4 aut | |
| 700 | 1 | |a Morales, Claudia Valverde |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Revista de oncología |d Barcelona : Doyma, 2000 |g 24(2022), 12 vom: 21. Aug., Seite 2475-2479 |w (DE-627)385985452 |w (DE-600)2143451-7 |x 1578-195X |7 nnns |
| 773 | 1 | 8 | |g volume:24 |g year:2022 |g number:12 |g day:21 |g month:08 |g pages:2475-2479 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1007/s12094-022-02912-w |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 912 | |a GBV_ILN_20 | ||
| 912 | |a GBV_ILN_22 | ||
| 912 | |a GBV_ILN_23 | ||
| 912 | |a GBV_ILN_24 | ||
| 912 | |a GBV_ILN_31 | ||
| 912 | |a GBV_ILN_39 | ||
| 912 | |a GBV_ILN_40 | ||
| 912 | |a GBV_ILN_60 | ||
| 912 | |a GBV_ILN_62 | ||
| 912 | |a GBV_ILN_65 | ||
| 912 | |a GBV_ILN_69 | ||
| 912 | |a GBV_ILN_70 | ||
| 912 | |a GBV_ILN_73 | ||
| 912 | |a GBV_ILN_74 | ||
| 912 | |a GBV_ILN_90 | ||
| 912 | |a GBV_ILN_95 | ||
| 912 | |a GBV_ILN_100 | ||
| 912 | |a GBV_ILN_105 | ||
| 912 | |a GBV_ILN_120 | ||
| 912 | |a GBV_ILN_152 | ||
| 912 | |a GBV_ILN_161 | ||
| 912 | |a GBV_ILN_171 | ||
| 912 | |a GBV_ILN_187 | ||
| 912 | |a GBV_ILN_224 | ||
| 912 | |a GBV_ILN_250 | ||
| 912 | |a GBV_ILN_281 | ||
| 912 | |a GBV_ILN_285 | ||
| 912 | |a GBV_ILN_293 | ||
| 912 | |a GBV_ILN_370 | ||
| 912 | |a GBV_ILN_602 | ||
| 912 | |a GBV_ILN_702 | ||
| 951 | |a AR | ||
| 952 | |d 24 |j 2022 |e 12 |b 21 |c 08 |h 2475-2479 | ||
| author_variant |
f c m fc fcm c n g cn cng r a j ra raj m n h mn mnh g a e ga gae s s a r ssa ssar l c p lc lcp s r m sr srm c v m cv cvm |
|---|---|
| matchkey_str |
article:1578195X:2022----::eutoauvynhtetetfdlsetadonautysroaa |
| hierarchy_sort_str |
2022 |
| publishDate |
2022 |
| allfields |
10.1007/s12094-022-02912-w doi (DE-627)SPR048361720 (SPR)s12094-022-02912-w-e DE-627 ger DE-627 rakwb eng Mata Fernández, Cristina verfasserin (orcid)0000-0001-9922-0078 aut Results of a survey on the treatment of adolescents and young adult (AYA) sarcoma patients in Spain at present time 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © The Author(s), under exclusive licence to Federación de Sociedades Españolas de Oncología (FESEO) 2022. Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. Introduction We aimed to analyse health care services for adolescents and young adults (AYA) with sarcomas in Spain. Methods A survey was sent to all Spanish cancer centres, including questions about demographic, facilities, and treatment strategies for AYAs with sarcomas in the last 2 years. Results Thirty-five units participated in the survey, 17 paediatric and 15 adult units. There were three specialized AYA units. First line regimen varied depending on whether the treating unit was paediatric or not, for osteosarcomas, rhabdomyosarcomas, and non-rhabdomyosarcomas. By contrast, 91.4% of Ewing sarcomas were treated according to EE2012. In the relapse setting, differences between units were higher in all tumours. Additionally, 48% of the units reported not having trials for this population. Conclusion There are major differences in the treatment of AYAs with sarcomas between adult and paediatric units. Enormous efforts are needed to homogenize treatments and increase the access to innovation. Adolescents (dpeaa)DE-He213 AYA oncology (dpeaa)DE-He213 Sarcoma (dpeaa)DE-He213 Clinical trials (dpeaa)DE-He213 AYA units (dpeaa)DE-He213 GEIS-SEHOP (dpeaa)DE-He213 Gutierrez Carrasco, Nacho aut Juan Ribelles, Antonio aut Hindi Muñiz, Nadia aut Estival González, Anna aut Rubio San Simón, Alba aut Portellano, Lucía Castillo aut Medina, Sofía Ruiz aut Morales, Claudia Valverde aut Enthalten in Revista de oncología Barcelona : Doyma, 2000 24(2022), 12 vom: 21. Aug., Seite 2475-2479 (DE-627)385985452 (DE-600)2143451-7 1578-195X nnns volume:24 year:2022 number:12 day:21 month:08 pages:2475-2479 https://dx.doi.org/10.1007/s12094-022-02912-w lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_90 GBV_ILN_95 GBV_ILN_100 GBV_ILN_105 GBV_ILN_120 GBV_ILN_152 GBV_ILN_161 GBV_ILN_171 GBV_ILN_187 GBV_ILN_224 GBV_ILN_250 GBV_ILN_281 GBV_ILN_285 GBV_ILN_293 GBV_ILN_370 GBV_ILN_602 GBV_ILN_702 AR 24 2022 12 21 08 2475-2479 |
| spelling |
10.1007/s12094-022-02912-w doi (DE-627)SPR048361720 (SPR)s12094-022-02912-w-e DE-627 ger DE-627 rakwb eng Mata Fernández, Cristina verfasserin (orcid)0000-0001-9922-0078 aut Results of a survey on the treatment of adolescents and young adult (AYA) sarcoma patients in Spain at present time 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © The Author(s), under exclusive licence to Federación de Sociedades Españolas de Oncología (FESEO) 2022. Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. Introduction We aimed to analyse health care services for adolescents and young adults (AYA) with sarcomas in Spain. Methods A survey was sent to all Spanish cancer centres, including questions about demographic, facilities, and treatment strategies for AYAs with sarcomas in the last 2 years. Results Thirty-five units participated in the survey, 17 paediatric and 15 adult units. There were three specialized AYA units. First line regimen varied depending on whether the treating unit was paediatric or not, for osteosarcomas, rhabdomyosarcomas, and non-rhabdomyosarcomas. By contrast, 91.4% of Ewing sarcomas were treated according to EE2012. In the relapse setting, differences between units were higher in all tumours. Additionally, 48% of the units reported not having trials for this population. Conclusion There are major differences in the treatment of AYAs with sarcomas between adult and paediatric units. Enormous efforts are needed to homogenize treatments and increase the access to innovation. Adolescents (dpeaa)DE-He213 AYA oncology (dpeaa)DE-He213 Sarcoma (dpeaa)DE-He213 Clinical trials (dpeaa)DE-He213 AYA units (dpeaa)DE-He213 GEIS-SEHOP (dpeaa)DE-He213 Gutierrez Carrasco, Nacho aut Juan Ribelles, Antonio aut Hindi Muñiz, Nadia aut Estival González, Anna aut Rubio San Simón, Alba aut Portellano, Lucía Castillo aut Medina, Sofía Ruiz aut Morales, Claudia Valverde aut Enthalten in Revista de oncología Barcelona : Doyma, 2000 24(2022), 12 vom: 21. Aug., Seite 2475-2479 (DE-627)385985452 (DE-600)2143451-7 1578-195X nnns volume:24 year:2022 number:12 day:21 month:08 pages:2475-2479 https://dx.doi.org/10.1007/s12094-022-02912-w lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_90 GBV_ILN_95 GBV_ILN_100 GBV_ILN_105 GBV_ILN_120 GBV_ILN_152 GBV_ILN_161 GBV_ILN_171 GBV_ILN_187 GBV_ILN_224 GBV_ILN_250 GBV_ILN_281 GBV_ILN_285 GBV_ILN_293 GBV_ILN_370 GBV_ILN_602 GBV_ILN_702 AR 24 2022 12 21 08 2475-2479 |
| allfields_unstemmed |
10.1007/s12094-022-02912-w doi (DE-627)SPR048361720 (SPR)s12094-022-02912-w-e DE-627 ger DE-627 rakwb eng Mata Fernández, Cristina verfasserin (orcid)0000-0001-9922-0078 aut Results of a survey on the treatment of adolescents and young adult (AYA) sarcoma patients in Spain at present time 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © The Author(s), under exclusive licence to Federación de Sociedades Españolas de Oncología (FESEO) 2022. Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. Introduction We aimed to analyse health care services for adolescents and young adults (AYA) with sarcomas in Spain. Methods A survey was sent to all Spanish cancer centres, including questions about demographic, facilities, and treatment strategies for AYAs with sarcomas in the last 2 years. Results Thirty-five units participated in the survey, 17 paediatric and 15 adult units. There were three specialized AYA units. First line regimen varied depending on whether the treating unit was paediatric or not, for osteosarcomas, rhabdomyosarcomas, and non-rhabdomyosarcomas. By contrast, 91.4% of Ewing sarcomas were treated according to EE2012. In the relapse setting, differences between units were higher in all tumours. Additionally, 48% of the units reported not having trials for this population. Conclusion There are major differences in the treatment of AYAs with sarcomas between adult and paediatric units. Enormous efforts are needed to homogenize treatments and increase the access to innovation. Adolescents (dpeaa)DE-He213 AYA oncology (dpeaa)DE-He213 Sarcoma (dpeaa)DE-He213 Clinical trials (dpeaa)DE-He213 AYA units (dpeaa)DE-He213 GEIS-SEHOP (dpeaa)DE-He213 Gutierrez Carrasco, Nacho aut Juan Ribelles, Antonio aut Hindi Muñiz, Nadia aut Estival González, Anna aut Rubio San Simón, Alba aut Portellano, Lucía Castillo aut Medina, Sofía Ruiz aut Morales, Claudia Valverde aut Enthalten in Revista de oncología Barcelona : Doyma, 2000 24(2022), 12 vom: 21. Aug., Seite 2475-2479 (DE-627)385985452 (DE-600)2143451-7 1578-195X nnns volume:24 year:2022 number:12 day:21 month:08 pages:2475-2479 https://dx.doi.org/10.1007/s12094-022-02912-w lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_90 GBV_ILN_95 GBV_ILN_100 GBV_ILN_105 GBV_ILN_120 GBV_ILN_152 GBV_ILN_161 GBV_ILN_171 GBV_ILN_187 GBV_ILN_224 GBV_ILN_250 GBV_ILN_281 GBV_ILN_285 GBV_ILN_293 GBV_ILN_370 GBV_ILN_602 GBV_ILN_702 AR 24 2022 12 21 08 2475-2479 |
| allfieldsGer |
10.1007/s12094-022-02912-w doi (DE-627)SPR048361720 (SPR)s12094-022-02912-w-e DE-627 ger DE-627 rakwb eng Mata Fernández, Cristina verfasserin (orcid)0000-0001-9922-0078 aut Results of a survey on the treatment of adolescents and young adult (AYA) sarcoma patients in Spain at present time 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © The Author(s), under exclusive licence to Federación de Sociedades Españolas de Oncología (FESEO) 2022. Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. Introduction We aimed to analyse health care services for adolescents and young adults (AYA) with sarcomas in Spain. Methods A survey was sent to all Spanish cancer centres, including questions about demographic, facilities, and treatment strategies for AYAs with sarcomas in the last 2 years. Results Thirty-five units participated in the survey, 17 paediatric and 15 adult units. There were three specialized AYA units. First line regimen varied depending on whether the treating unit was paediatric or not, for osteosarcomas, rhabdomyosarcomas, and non-rhabdomyosarcomas. By contrast, 91.4% of Ewing sarcomas were treated according to EE2012. In the relapse setting, differences between units were higher in all tumours. Additionally, 48% of the units reported not having trials for this population. Conclusion There are major differences in the treatment of AYAs with sarcomas between adult and paediatric units. Enormous efforts are needed to homogenize treatments and increase the access to innovation. Adolescents (dpeaa)DE-He213 AYA oncology (dpeaa)DE-He213 Sarcoma (dpeaa)DE-He213 Clinical trials (dpeaa)DE-He213 AYA units (dpeaa)DE-He213 GEIS-SEHOP (dpeaa)DE-He213 Gutierrez Carrasco, Nacho aut Juan Ribelles, Antonio aut Hindi Muñiz, Nadia aut Estival González, Anna aut Rubio San Simón, Alba aut Portellano, Lucía Castillo aut Medina, Sofía Ruiz aut Morales, Claudia Valverde aut Enthalten in Revista de oncología Barcelona : Doyma, 2000 24(2022), 12 vom: 21. Aug., Seite 2475-2479 (DE-627)385985452 (DE-600)2143451-7 1578-195X nnns volume:24 year:2022 number:12 day:21 month:08 pages:2475-2479 https://dx.doi.org/10.1007/s12094-022-02912-w lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_90 GBV_ILN_95 GBV_ILN_100 GBV_ILN_105 GBV_ILN_120 GBV_ILN_152 GBV_ILN_161 GBV_ILN_171 GBV_ILN_187 GBV_ILN_224 GBV_ILN_250 GBV_ILN_281 GBV_ILN_285 GBV_ILN_293 GBV_ILN_370 GBV_ILN_602 GBV_ILN_702 AR 24 2022 12 21 08 2475-2479 |
| allfieldsSound |
10.1007/s12094-022-02912-w doi (DE-627)SPR048361720 (SPR)s12094-022-02912-w-e DE-627 ger DE-627 rakwb eng Mata Fernández, Cristina verfasserin (orcid)0000-0001-9922-0078 aut Results of a survey on the treatment of adolescents and young adult (AYA) sarcoma patients in Spain at present time 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © The Author(s), under exclusive licence to Federación de Sociedades Españolas de Oncología (FESEO) 2022. Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. Introduction We aimed to analyse health care services for adolescents and young adults (AYA) with sarcomas in Spain. Methods A survey was sent to all Spanish cancer centres, including questions about demographic, facilities, and treatment strategies for AYAs with sarcomas in the last 2 years. Results Thirty-five units participated in the survey, 17 paediatric and 15 adult units. There were three specialized AYA units. First line regimen varied depending on whether the treating unit was paediatric or not, for osteosarcomas, rhabdomyosarcomas, and non-rhabdomyosarcomas. By contrast, 91.4% of Ewing sarcomas were treated according to EE2012. In the relapse setting, differences between units were higher in all tumours. Additionally, 48% of the units reported not having trials for this population. Conclusion There are major differences in the treatment of AYAs with sarcomas between adult and paediatric units. Enormous efforts are needed to homogenize treatments and increase the access to innovation. Adolescents (dpeaa)DE-He213 AYA oncology (dpeaa)DE-He213 Sarcoma (dpeaa)DE-He213 Clinical trials (dpeaa)DE-He213 AYA units (dpeaa)DE-He213 GEIS-SEHOP (dpeaa)DE-He213 Gutierrez Carrasco, Nacho aut Juan Ribelles, Antonio aut Hindi Muñiz, Nadia aut Estival González, Anna aut Rubio San Simón, Alba aut Portellano, Lucía Castillo aut Medina, Sofía Ruiz aut Morales, Claudia Valverde aut Enthalten in Revista de oncología Barcelona : Doyma, 2000 24(2022), 12 vom: 21. Aug., Seite 2475-2479 (DE-627)385985452 (DE-600)2143451-7 1578-195X nnns volume:24 year:2022 number:12 day:21 month:08 pages:2475-2479 https://dx.doi.org/10.1007/s12094-022-02912-w lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_90 GBV_ILN_95 GBV_ILN_100 GBV_ILN_105 GBV_ILN_120 GBV_ILN_152 GBV_ILN_161 GBV_ILN_171 GBV_ILN_187 GBV_ILN_224 GBV_ILN_250 GBV_ILN_281 GBV_ILN_285 GBV_ILN_293 GBV_ILN_370 GBV_ILN_602 GBV_ILN_702 AR 24 2022 12 21 08 2475-2479 |
| language |
English |
| source |
Enthalten in Revista de oncología 24(2022), 12 vom: 21. Aug., Seite 2475-2479 volume:24 year:2022 number:12 day:21 month:08 pages:2475-2479 |
| sourceStr |
Enthalten in Revista de oncología 24(2022), 12 vom: 21. Aug., Seite 2475-2479 volume:24 year:2022 number:12 day:21 month:08 pages:2475-2479 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
Adolescents AYA oncology Sarcoma Clinical trials AYA units GEIS-SEHOP |
| isfreeaccess_bool |
false |
| container_title |
Revista de oncología |
| authorswithroles_txt_mv |
Mata Fernández, Cristina @@aut@@ Gutierrez Carrasco, Nacho @@aut@@ Juan Ribelles, Antonio @@aut@@ Hindi Muñiz, Nadia @@aut@@ Estival González, Anna @@aut@@ Rubio San Simón, Alba @@aut@@ Portellano, Lucía Castillo @@aut@@ Medina, Sofía Ruiz @@aut@@ Morales, Claudia Valverde @@aut@@ |
| publishDateDaySort_date |
2022-08-21T00:00:00Z |
| hierarchy_top_id |
385985452 |
| id |
SPR048361720 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR048361720</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230509113857.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">221015s2022 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/s12094-022-02912-w</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR048361720</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)s12094-022-02912-w-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Mata Fernández, Cristina</subfield><subfield code="e">verfasserin</subfield><subfield code="0">(orcid)0000-0001-9922-0078</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Results of a survey on the treatment of adolescents and young adult (AYA) sarcoma patients in Spain at present time</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2022</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© The Author(s), under exclusive licence to Federación de Sociedades Españolas de Oncología (FESEO) 2022. Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Introduction We aimed to analyse health care services for adolescents and young adults (AYA) with sarcomas in Spain. Methods A survey was sent to all Spanish cancer centres, including questions about demographic, facilities, and treatment strategies for AYAs with sarcomas in the last 2 years. Results Thirty-five units participated in the survey, 17 paediatric and 15 adult units. There were three specialized AYA units. First line regimen varied depending on whether the treating unit was paediatric or not, for osteosarcomas, rhabdomyosarcomas, and non-rhabdomyosarcomas. By contrast, 91.4% of Ewing sarcomas were treated according to EE2012. In the relapse setting, differences between units were higher in all tumours. Additionally, 48% of the units reported not having trials for this population. Conclusion There are major differences in the treatment of AYAs with sarcomas between adult and paediatric units. Enormous efforts are needed to homogenize treatments and increase the access to innovation.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Adolescents</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">AYA oncology</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Sarcoma</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Clinical trials</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">AYA units</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">GEIS-SEHOP</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gutierrez Carrasco, Nacho</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Juan Ribelles, Antonio</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hindi Muñiz, Nadia</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Estival González, Anna</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rubio San Simón, Alba</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Portellano, Lucía Castillo</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Medina, Sofía Ruiz</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Morales, Claudia Valverde</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Revista de oncología</subfield><subfield code="d">Barcelona : Doyma, 2000</subfield><subfield code="g">24(2022), 12 vom: 21. Aug., Seite 2475-2479</subfield><subfield code="w">(DE-627)385985452</subfield><subfield code="w">(DE-600)2143451-7</subfield><subfield code="x">1578-195X</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:24</subfield><subfield code="g">year:2022</subfield><subfield code="g">number:12</subfield><subfield code="g">day:21</subfield><subfield code="g">month:08</subfield><subfield code="g">pages:2475-2479</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1007/s12094-022-02912-w</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_90</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_100</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_120</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_152</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_171</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_187</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_224</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_250</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_281</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_370</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_702</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">24</subfield><subfield code="j">2022</subfield><subfield code="e">12</subfield><subfield code="b">21</subfield><subfield code="c">08</subfield><subfield code="h">2475-2479</subfield></datafield></record></collection>
|
| author |
Mata Fernández, Cristina |
| spellingShingle |
Mata Fernández, Cristina misc Adolescents misc AYA oncology misc Sarcoma misc Clinical trials misc AYA units misc GEIS-SEHOP Results of a survey on the treatment of adolescents and young adult (AYA) sarcoma patients in Spain at present time |
| authorStr |
Mata Fernández, Cristina |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)385985452 |
| format |
electronic Article |
| delete_txt_mv |
keep |
| author_role |
aut aut aut aut aut aut aut aut aut |
| collection |
springer |
| remote_str |
true |
| illustrated |
Not Illustrated |
| issn |
1578-195X |
| topic_title |
Results of a survey on the treatment of adolescents and young adult (AYA) sarcoma patients in Spain at present time Adolescents (dpeaa)DE-He213 AYA oncology (dpeaa)DE-He213 Sarcoma (dpeaa)DE-He213 Clinical trials (dpeaa)DE-He213 AYA units (dpeaa)DE-He213 GEIS-SEHOP (dpeaa)DE-He213 |
| topic |
misc Adolescents misc AYA oncology misc Sarcoma misc Clinical trials misc AYA units misc GEIS-SEHOP |
| topic_unstemmed |
misc Adolescents misc AYA oncology misc Sarcoma misc Clinical trials misc AYA units misc GEIS-SEHOP |
| topic_browse |
misc Adolescents misc AYA oncology misc Sarcoma misc Clinical trials misc AYA units misc GEIS-SEHOP |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
cr |
| hierarchy_parent_title |
Revista de oncología |
| hierarchy_parent_id |
385985452 |
| hierarchy_top_title |
Revista de oncología |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)385985452 (DE-600)2143451-7 |
| title |
Results of a survey on the treatment of adolescents and young adult (AYA) sarcoma patients in Spain at present time |
| ctrlnum |
(DE-627)SPR048361720 (SPR)s12094-022-02912-w-e |
| title_full |
Results of a survey on the treatment of adolescents and young adult (AYA) sarcoma patients in Spain at present time |
| author_sort |
Mata Fernández, Cristina |
| journal |
Revista de oncología |
| journalStr |
Revista de oncología |
| lang_code |
eng |
| isOA_bool |
false |
| recordtype |
marc |
| publishDateSort |
2022 |
| contenttype_str_mv |
txt |
| container_start_page |
2475 |
| author_browse |
Mata Fernández, Cristina Gutierrez Carrasco, Nacho Juan Ribelles, Antonio Hindi Muñiz, Nadia Estival González, Anna Rubio San Simón, Alba Portellano, Lucía Castillo Medina, Sofía Ruiz Morales, Claudia Valverde |
| container_volume |
24 |
| format_se |
Elektronische Aufsätze |
| author-letter |
Mata Fernández, Cristina |
| doi_str_mv |
10.1007/s12094-022-02912-w |
| normlink |
(ORCID)0000-0001-9922-0078 |
| normlink_prefix_str_mv |
(orcid)0000-0001-9922-0078 |
| title_sort |
results of a survey on the treatment of adolescents and young adult (aya) sarcoma patients in spain at present time |
| title_auth |
Results of a survey on the treatment of adolescents and young adult (AYA) sarcoma patients in Spain at present time |
| abstract |
Introduction We aimed to analyse health care services for adolescents and young adults (AYA) with sarcomas in Spain. Methods A survey was sent to all Spanish cancer centres, including questions about demographic, facilities, and treatment strategies for AYAs with sarcomas in the last 2 years. Results Thirty-five units participated in the survey, 17 paediatric and 15 adult units. There were three specialized AYA units. First line regimen varied depending on whether the treating unit was paediatric or not, for osteosarcomas, rhabdomyosarcomas, and non-rhabdomyosarcomas. By contrast, 91.4% of Ewing sarcomas were treated according to EE2012. In the relapse setting, differences between units were higher in all tumours. Additionally, 48% of the units reported not having trials for this population. Conclusion There are major differences in the treatment of AYAs with sarcomas between adult and paediatric units. Enormous efforts are needed to homogenize treatments and increase the access to innovation. © The Author(s), under exclusive licence to Federación de Sociedades Españolas de Oncología (FESEO) 2022. Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. |
| abstractGer |
Introduction We aimed to analyse health care services for adolescents and young adults (AYA) with sarcomas in Spain. Methods A survey was sent to all Spanish cancer centres, including questions about demographic, facilities, and treatment strategies for AYAs with sarcomas in the last 2 years. Results Thirty-five units participated in the survey, 17 paediatric and 15 adult units. There were three specialized AYA units. First line regimen varied depending on whether the treating unit was paediatric or not, for osteosarcomas, rhabdomyosarcomas, and non-rhabdomyosarcomas. By contrast, 91.4% of Ewing sarcomas were treated according to EE2012. In the relapse setting, differences between units were higher in all tumours. Additionally, 48% of the units reported not having trials for this population. Conclusion There are major differences in the treatment of AYAs with sarcomas between adult and paediatric units. Enormous efforts are needed to homogenize treatments and increase the access to innovation. © The Author(s), under exclusive licence to Federación de Sociedades Españolas de Oncología (FESEO) 2022. Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. |
| abstract_unstemmed |
Introduction We aimed to analyse health care services for adolescents and young adults (AYA) with sarcomas in Spain. Methods A survey was sent to all Spanish cancer centres, including questions about demographic, facilities, and treatment strategies for AYAs with sarcomas in the last 2 years. Results Thirty-five units participated in the survey, 17 paediatric and 15 adult units. There were three specialized AYA units. First line regimen varied depending on whether the treating unit was paediatric or not, for osteosarcomas, rhabdomyosarcomas, and non-rhabdomyosarcomas. By contrast, 91.4% of Ewing sarcomas were treated according to EE2012. In the relapse setting, differences between units were higher in all tumours. Additionally, 48% of the units reported not having trials for this population. Conclusion There are major differences in the treatment of AYAs with sarcomas between adult and paediatric units. Enormous efforts are needed to homogenize treatments and increase the access to innovation. © The Author(s), under exclusive licence to Federación de Sociedades Españolas de Oncología (FESEO) 2022. Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. |
| collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_90 GBV_ILN_95 GBV_ILN_100 GBV_ILN_105 GBV_ILN_120 GBV_ILN_152 GBV_ILN_161 GBV_ILN_171 GBV_ILN_187 GBV_ILN_224 GBV_ILN_250 GBV_ILN_281 GBV_ILN_285 GBV_ILN_293 GBV_ILN_370 GBV_ILN_602 GBV_ILN_702 |
| container_issue |
12 |
| title_short |
Results of a survey on the treatment of adolescents and young adult (AYA) sarcoma patients in Spain at present time |
| url |
https://dx.doi.org/10.1007/s12094-022-02912-w |
| remote_bool |
true |
| author2 |
Gutierrez Carrasco, Nacho Juan Ribelles, Antonio Hindi Muñiz, Nadia Estival González, Anna Rubio San Simón, Alba Portellano, Lucía Castillo Medina, Sofía Ruiz Morales, Claudia Valverde |
| author2Str |
Gutierrez Carrasco, Nacho Juan Ribelles, Antonio Hindi Muñiz, Nadia Estival González, Anna Rubio San Simón, Alba Portellano, Lucía Castillo Medina, Sofía Ruiz Morales, Claudia Valverde |
| ppnlink |
385985452 |
| mediatype_str_mv |
c |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| doi_str |
10.1007/s12094-022-02912-w |
| up_date |
2024-07-03T18:43:30.440Z |
| _version_ |
1803584495095382017 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR048361720</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230509113857.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">221015s2022 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/s12094-022-02912-w</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR048361720</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)s12094-022-02912-w-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Mata Fernández, Cristina</subfield><subfield code="e">verfasserin</subfield><subfield code="0">(orcid)0000-0001-9922-0078</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Results of a survey on the treatment of adolescents and young adult (AYA) sarcoma patients in Spain at present time</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2022</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© The Author(s), under exclusive licence to Federación de Sociedades Españolas de Oncología (FESEO) 2022. Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Introduction We aimed to analyse health care services for adolescents and young adults (AYA) with sarcomas in Spain. Methods A survey was sent to all Spanish cancer centres, including questions about demographic, facilities, and treatment strategies for AYAs with sarcomas in the last 2 years. Results Thirty-five units participated in the survey, 17 paediatric and 15 adult units. There were three specialized AYA units. First line regimen varied depending on whether the treating unit was paediatric or not, for osteosarcomas, rhabdomyosarcomas, and non-rhabdomyosarcomas. By contrast, 91.4% of Ewing sarcomas were treated according to EE2012. In the relapse setting, differences between units were higher in all tumours. Additionally, 48% of the units reported not having trials for this population. Conclusion There are major differences in the treatment of AYAs with sarcomas between adult and paediatric units. Enormous efforts are needed to homogenize treatments and increase the access to innovation.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Adolescents</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">AYA oncology</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Sarcoma</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Clinical trials</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">AYA units</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">GEIS-SEHOP</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gutierrez Carrasco, Nacho</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Juan Ribelles, Antonio</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hindi Muñiz, Nadia</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Estival González, Anna</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rubio San Simón, Alba</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Portellano, Lucía Castillo</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Medina, Sofía Ruiz</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Morales, Claudia Valverde</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Revista de oncología</subfield><subfield code="d">Barcelona : Doyma, 2000</subfield><subfield code="g">24(2022), 12 vom: 21. Aug., Seite 2475-2479</subfield><subfield code="w">(DE-627)385985452</subfield><subfield code="w">(DE-600)2143451-7</subfield><subfield code="x">1578-195X</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:24</subfield><subfield code="g">year:2022</subfield><subfield code="g">number:12</subfield><subfield code="g">day:21</subfield><subfield code="g">month:08</subfield><subfield code="g">pages:2475-2479</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1007/s12094-022-02912-w</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_90</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_100</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_120</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_152</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_171</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_187</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_224</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_250</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_281</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_370</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_702</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">24</subfield><subfield code="j">2022</subfield><subfield code="e">12</subfield><subfield code="b">21</subfield><subfield code="c">08</subfield><subfield code="h">2475-2479</subfield></datafield></record></collection>
|
| score |
7.4013157 |